Stock Track | iHuman (IH) Soars 5.04% on Strong Q1 Results and Expanded Educational Offerings

Stock Track
Yesterday

Shares of iHuman Inc. (IH) surged 5.04% in pre-market trading on Thursday following the release of its first quarter 2025 unaudited financial results and the announcement of expanded educational offerings. The leading provider of tech-powered, intellectual development products in China continues to show resilience and growth despite challenging market conditions.

The company reported Q1 revenues of RMB210.4 million (US$29.0 million), achieving its 13th consecutive quarter of profitability. While this represents a slight decrease from RMB235.0 million in the same period last year, iHuman demonstrated strong cost management and operational efficiency. The company's gross profit stood at RMB143.8 million (US$19.8 million) with a gross margin of 68.3%, while operating income increased to RMB21.6 million (US$3.0 million) compared to RMB17.5 million in the previous year.

Investors were particularly encouraged by iHuman's strategic initiatives and product expansions. The company has broadened its content library, introduced new learning modules, and launched innovative devices such as the iHuman All-Subject Master. Furthermore, iHuman's collaboration with Oxford University Press and the integration of AI capabilities across its offerings signal strong potential for future growth. The company's focus on international expansion and commitment to delivering high-quality, impactful products for children's holistic development appear to be resonating well with the market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10